Financials
Value Q1, 25Q2, 25Q3, 25 TTM Selling/general/admin expenses 162.79 M211.11 M176.74 M — Research & development 65.46 M69.65 M67.52 M — Operating income 96.22 M156.53 M30.39 M — Non-Operating Income, Total ——— — Interest expense, net of interest capitalized 4.61 M4.77 M4.32 M — Non-Operating Income, excl. Interest Expenses ——— — Unusual income/expense ——— — Pretax income 37.45 M84.22 M-25.15 M — Equity in earnings ——— — Taxes 36.95 M-21.06 M-4.95 M — Non-controlling/minority interest ——— — After tax other income/expense ——— — Net income before discontinued operations 502 K105.28 M-20.2 M — Discontinued operations ——— — Net income 502 K105.28 M-20.2 M — Dilution adjustment ——— — Preferred dividends ——— — Diluted net income available to common stockholders 502 K105.28 M-20.2 M — Basic earnings per share (Basic EPS) 00.57-0.11 — Diluted earnings per share (Diluted EPS) 00.57-0.11 — Average basic shares outstanding 166.61 M185.17 M191 M — Diluted shares outstanding 166.61 M185.83 M191 M — EBITDA 184.08 M249.35 M126.06 M — EBIT 96.22 M156.53 M30.39 M — Cost of revenue 123.38 M139.08 M63.84 M — Other cost of goods sold 123.38 M139.08 M63.84 M — Depreciation & amortization (cash flow) 87.85 M92.82 M95.67 M —